Myriad Genetics | MYGN - Loan Capital


Myriad Genetics reported $120.7M in Loan Capital for its fiscal quarter ending in June of 2026.





Loan Capital Change Date
Agilent USD 3.05B 1000K Mar/2026
Becton, Dickinson and Co. USD 13.51B 1.2B Jun/2026
Bio-Rad Laboratories USD 803M 100K Jun/2026
Bruker USD 1.81B 151.8M Jun/2026
Danaher USD 25.15B 7.59B Jun/2026
Illumina USD 1.49B 1000K Jun/2026
J&J USD 37.34B 183M Jun/2026
Mettler Toledo International USD 2.04B 116.92M Jun/2026
Myriad Genetics USD 120.7M 400K Jun/2026
OraSure Technologies USD 100K 17K Dec/2025
Pacific Biosciences Of California USD 645.38M 223K Dec/2025
Quest Diagnostics USD 5.63B 477M Jun/2026
Quidel USD 2.54B 2.54B Jun/2026
Repligen USD 551.05M 4.46M Jun/2026
Revvity USD 2.63B 1.02M Jun/2026
Standard Biotools USD 299K 0 Mar/2026
Thermo Fisher Scientific USD 39.18B 890M Jun/2026
Veracyte USD 0 0 Mar/2025
Waters USD 5.09B 129M Jun/2026